Ocuphire Pharma Inc. buy Cantor Fitzgerald
Start price
14.08.23
/
50%
€3.83
Target price
14.08.24
€15.55
Performance (%)
-59.53%
Price
17.05.24
€1.55
Summary
This prediction is currently active. Massive losses of -59.53% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 14.08.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ocuphire Pharma Inc. | -0.257% | -0.257% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Ocuphire Pharma Inc. diskutieren
Ocuphire Pharma, Inc. (NASDAQ: OCUP) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $17.00 price target on the stock.
Ratings data for OCUP provided by MarketBeat